Antiplatelet drugs

European Journal of Clinical Investigation
G A Fitzgerald, E A Meagher

Abstract

The evidence in support of the safety and efficacy of aspirin in the secondary prevention of platelet dependent vascular occlusion is compelling. The utility of this drug has stalled the development of potential competitors, such as thromboxane antagonists. The emergence of glycoprotein IIb/IIIa antagonists as the most promising competitors for aspirin has focused attention on the possibility of delivering these drugs at an effective dose safely.

References

Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T Hla, K Neilson
Sep 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J L MillerL O Drouet
Oct 17, 1991·The New England Journal of Medicine·R J ClarkeG A FitzGerald
Oct 31, 1991·The New England Journal of Medicine·UNKNOWN Dutch TIA Trial Study GroupAnet van Latum
Mar 24, 1990·Lancet·J R O'Brien
Mar 31, 1990·Lancet·D J FitzgeraldG A FitzGerald
Jul 1, 1990·Circulation·G A FitzGerald
Jul 20, 1989·The New England Journal of Medicine·UNKNOWN Steering Committee of the Physicians' Health Study Research Group
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D L DeWitt, W L Smith
Feb 1, 1985·The Journal of Clinical Investigation·G Di MinnoM Mancini
Oct 9, 1986·The New England Journal of Medicine·C T ShermanL Morgenstern
Oct 16, 1986·The New England Journal of Medicine·D J FitzgeraldG A FitzGerald
May 14, 1987·The New England Journal of Medicine·G A FitzGerald
Mar 1, 1986·Journal of the American College of Cardiology·J A AmbroseV Fuster
Mar 1, 1972·Journal of Pharmaceutical Sciences·M RowlandS D Sholkoff
Nov 1, 1993·British Journal of Clinical Pharmacology·W N CharmanG A Fitzgerald

❮ Previous
Next ❯

Citations

Sep 25, 2003·Plastic and Reconstructive Surgery·Frank W PeterJohn H Barker
Aug 1, 1995·European Journal of Clinical Investigation·T C WascherG J Krejs
Jun 1, 1996·The Journal of Pharmacy and Pharmacology·P DurandD Blache
Jan 1, 1996·Pharmacology & Therapeutics·R A Armstrong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.